Papillomavirus Research

Papillomavirus Research aims to publish top quality articles, describing innovative research advances in the field of human tumour virology, including Epstein Barr virus (EBV), Human T cell leukemia virus (HTLV), Polyoma virus (PyV), Merkel Cell PolyomaVirus (MCPyV), Kaposi's Sarcoma Herpes Virus (KSHV) and Papillomaviruses (PV), as well as other related animal tumour virus models. We particularly wish to encourage mechanistic studies, exploring fundamental cancer mechanisms that are relevant to how viruses drive malignant progression, but which are also able to inform cancer research in general. Papers describing the use of, for example, adenoviruses or other viruses as tools for investigating tumour biology, or as preventative or therapeutic agents, will also be encouraged. This open access publication wishes to facilitate the publication of innovative articles of broad general appeal that bring together multifaceted contributions from virologists, immunologists, epidemiologists, clinicians and public health researchers. This journal seeks to promote dialogue and understanding of virus-induced cancers and to have a major impact on improvements to prevention, treatment and diagnosis in virus-associated tumours. Routine descriptive or repetitious studies are discouraged.